362 related articles for article (PubMed ID: 8926746)
1. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
[TBL] [Abstract][Full Text] [Related]
2. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
[TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.
Moody DE; Fang WB; Andrenyak DM; Monti KM; Jones C
J Anal Toxicol; 2006; 30(1):50-6. PubMed ID: 16620532
[TBL] [Abstract][Full Text] [Related]
4. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Kim SY; Kim H; Park Y; Lim J; Kim J; Koo SH; Kwon GC
J Anal Toxicol; 2017 Jun; 41(5):412-420. PubMed ID: 28201761
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments.
Peace MR; Poklis JL; Tarnai LD; Poklis A
J Anal Toxicol; 2002 Oct; 26(7):500-3. PubMed ID: 12423007
[TBL] [Abstract][Full Text] [Related]
8. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
[TBL] [Abstract][Full Text] [Related]
9. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
[TBL] [Abstract][Full Text] [Related]
10. Disposable electrochemical immunosensor array for the multiplexed detection of the drug metabolites morphine, tetrahydrocannabinol and benzoylecgonine.
Eissa S; Almthen RA; Zourob M
Mikrochim Acta; 2019 Jul; 186(8):523. PubMed ID: 31292788
[TBL] [Abstract][Full Text] [Related]
11. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
Korte T; Pykäläinen J; Lillsunde P; Seppälä T
J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
[TBL] [Abstract][Full Text] [Related]
12. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
[TBL] [Abstract][Full Text] [Related]
13. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
ElSohly MA; Stanford DF; Murphy TP; Lester BM; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HC
J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
[TBL] [Abstract][Full Text] [Related]
14. Screening for drugs of abuse with the Roche ONTRAK assays.
Armbruster DA; Krolak JM
J Anal Toxicol; 1992; 16(3):172-5. PubMed ID: 1522711
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
Poklis A; Poklis JL; Tarnai LD; Backer RC
J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
[TBL] [Abstract][Full Text] [Related]
16. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
Peace MR; Tarnai LD; Poklis A
J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase extraction and HPLC-UV confirmation of drugs of abuse in urine.
Ferrara SD; Tedeschi L; Frison G; Castagna F
J Anal Toxicol; 1992; 16(4):217-22. PubMed ID: 1323732
[TBL] [Abstract][Full Text] [Related]
19. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
